|
2023 Journal Article Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocolDissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O'Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan and Bakker, Arnold (2023). Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol. Pilot and Feasibility Studies, 9 (1) 189, 189. doi: 10.1186/s40814-023-01406-y |
|
2023 Other Outputs Cognitive subtypes in Parkinson’s disease: exploring phenotypes, neuroimaging targets, and therapeuticsPourzinal, Dana (2023). Cognitive subtypes in Parkinson’s disease: exploring phenotypes, neuroimaging targets, and therapeutics. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/063c937 |
|
2023 Journal Article Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's diseasePourzinal, Dana, Yang, Jihyun, Sivakumaran, Kumareshan, McMahon, Katie L., Mitchell, Leander, O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2023). Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease. Brain and Behavior, 13 (10) e3218, e3218. doi: 10.1002/brb3.3218 |
|
2023 Journal Article Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's diseaseYang, Jihyun, Pourzinal, Dana, Byrne, Gerard J., McMahon, Katie L., Copland, David A., O’Sullivan, John D., Mitchell, Leander and Dissanayaka, Nadeeka N. (2023). Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease. International Journal of Geriatric Psychiatry, 38 (6) e5955, e5955. doi: 10.1002/gps.5955 |
|
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Centre for Clinical Research HDR Symposium, Brisbane, QLD Australia, 24 November 2022. |
|
2022 Journal Article Systematic review of data‐driven cognitive subtypes in Parkinson’s diseasePourzinal, Dana, Yang, Jihyun, Lawson, Rachael A., McMahon, Katie L., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2022). Systematic review of data‐driven cognitive subtypes in Parkinson’s disease. European Journal of Neurology, 29 (11), 3395-3417. doi: 10.1111/ene.15481 |
|
2022 Journal Article Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairmentYang, Jihyun, McMahon, Katie L., Copland, David A., Pourzinal, Dana, Byrne, Gerard J., Angwin, Anthony J., O’Sullivan, John D. and Dissanayaka, Nadeeka N (2022). Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment. Brain Imaging and Behavior, 16 (6), 1-12. doi: 10.1007/s11682-022-00698-7 |
|
2022 Journal Article The Attention Network Test in Parkinson and Lewy body disease: a systematic reviewYang, Jihyun, Pourzinal, Dana, Rheinberger, Toby, Copland, David A., McMahon, Katie L., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2022). The Attention Network Test in Parkinson and Lewy body disease: a systematic review. Cognitive and Behavioral Neurology, 35 (1), 1-13. doi: 10.1097/WNN.0000000000000292 |
|
2022 Conference Publication Functional magnetic resonance imaging of the hippocampus as biomarker for cognitive decline in Parkinson’s diseasePourzinal, D., Yang, J., Byrne, G.J., O’Sullivan, J.D., McMahon, K. and Dissanayaka, N. (2022). Functional magnetic resonance imaging of the hippocampus as biomarker for cognitive decline in Parkinson’s disease. UQ Faculty of Medicine HDR Student Symposium, Brisbane, QLD, Australia, 7 October 2022. |
|
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Neurosciences Symposium, Brisbane, QLD Australia, 26-27 September 2022. |
|
2021 Journal Article Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementiaDissanayaka, Nadeeka N., Forbes, Elana J., Yang, Ji Hyun J., Pourzinal, Dana, O’Sullivan, John D., Mitchell, Leander K., Copland, David A., McMahon, Katie L. and Byrne, Gerard J. (2021). Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia. Journal of Neurology, 269 (3), 1600-1609. doi: 10.1007/s00415-021-10736-x |
|
2021 Journal Article Hippocampal correlates of episodic memory in Parkinson's disease: A systematic review of magnetic resonance imaging studiesPourzinal, Dana, Yang, Ji Hyun J., Bakker, Arnold, McMahon, Katie L., Byrne, Gerard J., Pontone, Gregory M., Mari, Zoltan and Dissanayaka, Nadeeka N. (2021). Hippocampal correlates of episodic memory in Parkinson's disease: A systematic review of magnetic resonance imaging studies. Journal of Neuroscience Research, 99 (9) jnr.24863, 2097-2116. doi: 10.1002/jnr.24863 |
|
2021 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J., Adam, R., Copland, D., Yang, J.H.J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2021). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocol. Australia Dementia Forum 2021, Online, 31 May - 1 June 2021. |
|
2021 Journal Article Neural correlates of attentional deficits in Parkinson’s disease patients with mild cognitive impairmentYang, Jihyun, Pourzinal, Dana, McMahon, Katie L., Byrne, Gerard J., Copland, David A., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2021). Neural correlates of attentional deficits in Parkinson’s disease patients with mild cognitive impairment. Parkinsonism and Related Disorders, 85, 17-22. doi: 10.1016/j.parkreldis.2021.02.009 |
|
2021 Conference Publication Investigating resting state functional connectivity in sub-phenotypes of mild cognitive impairment in Parkinson’s diseasePourzinal, D., Yang, J.H., Byrne, G.J., O’Sullivan, J.D., McMahon, K., Copland, D.A. and Dissanayaka, N. (2021). Investigating resting state functional connectivity in sub-phenotypes of mild cognitive impairment in Parkinson’s disease. Australia Dementia Forum 2021, Online, 31 May – 1 June 2021. |
|
2021 Conference Publication Systematic review of Magnetic Resonance Imaging studies exploring hippocampal correlates of episodic memory in Parkinson’s diseasePourzinal, D., Yang, J., Bakker, A., McMahon, K. L., Byrne, G. J., Pontone, G., Mari, Z. and Dissanayaka, N. (2021). Systematic review of Magnetic Resonance Imaging studies exploring hippocampal correlates of episodic memory in Parkinson’s disease. 6th Pacific Rim Conference 2021, Melbourne, VIC, Australia, 30 Jun-3 Jul 2021. |
|
2020 Conference Publication Identification and clinical characteristics of mild cognitive impairment in Parkinson's diseaseYang, J., Forbes, E., Pourzinal, D., McMahon, K., Copland, D., Byrne, G., O'Sullivan, J., Mitchell, L. and Dissanayaka, N. (2020). Identification and clinical characteristics of mild cognitive impairment in Parkinson's disease. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s diseasePourzinal, D., Yang, J. H., Byrne, G. J., O'Sullivan, J. D., Mitchell, L. K., McMahon, K. L., Copland, D. A. and Dissanayaka, N. N. W. (2020). Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s disease. Australian Society for Medical Research Queensland Postgraduate Student Conference, Online, 11 November 2020. |
|
2020 Conference Publication Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2020). Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocol. UQ Faculty of Medicine Higher Degree by Research Student Symposium, Brisbane, QLD Australia, 23-27 November 2020. |
|
2020 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, G. and Dissanayaka, N. (2020). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocol. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020. |
